> Visiting Washington/Alaska Chapter | Local links | End Visit > visit Canadian site

 

Live Help

View All Chapters

HOME
PATIENT SERVICES
DISEASE INFORMATION
Facts & Statistics
Leukemia
Lymphoma
Hodgkin Lymphoma
Hodgkin Facts/Stats
Non-Hodgkin Lymphoma
Non-Hodgkin Facts/Stats
Myeloma
Myelodysplastic Syndromes
Myeloproliferative Disorders
Other Blood Cancers
Childhood Blood Cancers
Treatment & Clinical Trials
National Education Programs
Free Materials
Signs and Symptoms
HOW TO HELP
ADVOCACY
SCIENCE/PROFESSIONALS
LLS
Email:
Password:
Remember Me
Not Yet Registered?



This website is certified by Health On the Net Foundation. Click to verify.
Disease Information
Disease Information > Lymphoma  print page
email page
 $  Donate
Society News Feeds

Lymphoma

Drug Co Pay ProgramCo-Pay Assistance Program now available for patients with Hodgkin and Non-Hodgkin Lymphoma

Lymphoma Education Series
For patients, families, and healthcare professionals


Lymphoma Webcasts

 
Stories of life and hope live
in Life Mosaic


Additional Information


Free Materials


Join The Discussion


Lymphoma Information


Subscribe to one of LLS's Monthly Newsletters
Name:
Email:
Zip/Postal Code:
eNewsline
LeukemiaLinks
LymphomaLinks
MyelomaLinks
Hematologic Cancer News

 

About Lymphoma
Causes and Risk Factors
Incidence
Get More Information
Contact Us

About Lymphoma 

Lymphoma is the name for a group of blood cancers that develop in the lymphatic system. Hodgkin lymphoma and non-Hodgkin lymphoma (NHL) are the two main types of lymphoma. 

Lymphoma originates in the lymphatic system.  The lymphatic system is part of the body's immune system, which is the body's defense against infection.  The marrow and lymphocytes are part of the immune system. Some other parts of the immune system are the lymph nodes, the lymphatic vessels and the spleen

Lymphoma starts with a change to a lymphocyte. The change to the lymphocyte causes it to become a lymphoma cell. The lymphoma cells pile up and form masses that gather in the lymph nodes or other parts of the lymphatic system. 

In 2009, about 601,180 people are living with lymphoma or are in remission. This number includes about 148,460 people with Hodgkin lymphoma and about 452,720 people with  non-Hodgkin lymphoma.

Hodgkin lymphoma has characteristics that distinguish it from other diseases classified as lymphoma, including the presence of Reed-Sternberg cells. These are large, malignant cell found in Hodgkin lymphoma tissues and named for the scientists who first identified them.

Non-Hodgkin lymphoma (NHL) represents a diverse group of diseases that are distinguished by the characteristics of the cancer cells associated with each disease type.

Return to top

Causes and Risk Factors

Hodgkin Lymphoma

Doctors don't know what causes most cases of Hodgkin lymphoma. Most cases occur in people who do not have identifiable risk factors.  However, a few risks factors are associated with Hodgkin lymphoma:
 
  • A history of confirmed infectious mononucleosis confers a three-fold increased risk of developing young-adult Hodgkin lymphoma compared to the risk incurred by the general population.

  • People infected with human T-cell lymphocytotropic virus (HTLV) or human immunodeficiency virus (HIV) also have an increased probability of developing Hodgkin lymphoma.

     
  • There are occasional cases of familial clustering, as with other cancers, and there is an increase in the incidence of Hodgkin lymphoma in siblings of patients with the disease. These cases are uncommon, but doctors are studying why there is a higher incidence of lymphoma for some families.

Non-Hodgkin Lymphoma

The reasons for the development of NHL are not known. Immune suppression plays a role in certain cases.

People infected with the human immunodeficiency virus (HIV) have a higher risk of developing lymphoma. There is a higher incidence of NHL in farming communities. Studies suggest that specific ingredients in herbicides and pesticides such as organochlorine, organophosphate and phenoxyacid compounds are linked to lymphoma. The number of lymphoma cases caused by such exposures has not been determined.

Exposure to certain viruses and bacteria is associated with NHL.  It is thought that infection with a virus or bacterium can lead to intense lymphoid cell proliferation, increasing the probability of a cancer-causing event in a cell. Some examples include

  • Epstein-Barr virus (EBV) infection—in patients from specific geographical regions—is strongly associated with African Burkitt lymphoma. The role of the virus is unclear since African Burkitt lymphoma also occurs among people who have not been infected with EBV. Epstein-Barr virus infection may play a role in the increased risk of NHL in persons whose immune systems are suppressed as a result of organ transplantation and its associated therapy.


  • Human T-lymphotropic virus (HTLV) is associated with a type of T-cell lymphoma in patients from certain geographic regions in Southern Japan, the Caribbean, South America and Africa.


  • The bacterium Helicobacter pylori causes ulcers in the stomach and is associated with the development of mucosa-associated lymphoid tissue (MALT) lymphoma in the stomach wall.

About a dozen inherited syndromes can predispose individuals to later development of NHL. These inherited disorders are uncommon, but the concept of predisposition genes is under study to determine if they play a role in the sporadic occurrence of NHL in otherwise healthy individuals.

Return to top


Incidence

About 74,490 people living in the United States will be diagnosed with lymphoma in 2009 (8,510 cases of Hodgkin lymphoma and 65,980 cases of NHL).

The incidence of Hodgkin lymphoma is consistently lower than that of NHL. Incidence rates for Hodgkin lymphoma tend to be higher among males than among females.

NHL is more common in males than in females. NHL is the seventh most common cancer in males and females in the United States.

Lymphoma (Hodgkin lymphoma, 7.2 percent; NHL, 6.6 percent) is the third most common cancer in children. In 2009, children younger than 15 years will comprise more than 4.5 percent of all Hodgkin lymphoma cases expected to be diagnosed and 0.7 percent of all NHL cases expected to be diagnosed.

Return to top

Get More Information

LLS offers ongoing education programs featuring leading lymphoma specialists discussing the latest issues in the diagnosis and treatment of lymphoma. Visit the Lymphoma Education Series page to find out about upcoming and archived programs. These programs are offered at no charge.

To learn more about the different types of lymphoma, lymphoma treatment, supportive care and resources for patients and caregivers, please visit the LLS Web pages Hodgkin Lymphoma and Non-Hodgkin Lymphoma. You can also view, print or order the following free LLS booklets

Return to top

Contact Us

The Leukemia & Lymphoma Society
1311 Mamaroneck Ave.
White Plains, NY 10605

or call the Information Resource Center at (800) 955-4572.




Hodgkin Lymphoma - In 2009, about 601,180 people are living with lymphoma or are in remission. This number includes about 148,460 people with Hodgkin lymphoma and about 452,720 people with Non-Hodgkin lymphoma. It is estimated that Hodgkin lymphoma will represent 11.4 percent of all types of lymphoma diagnosed in 2009. Hodgkin lymphoma is one of the most curable forms of cancer. It can be cured in about 75 percent of all patients. Hodgkin lymphoma is distinguished from other types of lymphoma by the presence of Reed-Sternberg cells (named for the scientists who first identified them).

Hodgkin Facts/Stats - Hodgkin lymphoma (also known as Hodgkin's disease) is a specialized form of lymphoma and represents about 11.5 percent of all lymphomas diagnosed each year

Non-Hodgkin Lymphoma - In 2009, about 601,180 people are living with lymphoma or are in remission. This number includes about 148,460 people with Hodgkin lymphoma and about 452,720 people with Non-Hodgkin lymphoma. It is estimated that approximately 65,980 new cases of non-Hodgkin lymphoma (NHL) will be diagnosed this year in the United States.

Non-Hodgkin Facts/Stats - Facts & statistics on non-Hodgkin lymphoma.



back to top

last updated on 10/22/09

The Leukemia & Lymphoma Society® (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services.
Need Help? Contact us by email, mail, or call (800) 955-4572 copyright | disclaimer | link | privacy | security
spanish french portuguese